Education
About Us
Working with TipRanks
Follow Us
Regeneron Pharmaceuticals (REGN)
NASDAQ:REGN
Regeneron (REGN) Ownership Overview
1.97% Insiders
24.24% Mutual Funds
19.48% Other Institutional Investors
28.51% ETFs
25.80% Public Companies and Individual Investors
The ownership structure of Regeneron (REGN) stock is a mix of institutional, retail, and individual investors. Approximately 72.23% of the company’s stock is owned by Institutional Investors, 1.97% is owned by Insiders, and 25.80% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 10, 2025 | xxxxxxxxxxxxx | $280766 | |
Oct 31, 2025 | xxxxxxxxxxxxx | $4252745 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $20840 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $74871 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $84905 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $362778 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,720,958 | Institution | 7.43% | 5,758,058,848 | |
| 6,645,779 | Institution | 6.40% | 4,956,222,605 | |
| 5,158,491 | Institution | 4.96% | 3,847,047,833 | |
| 4,596,358 | Institution | 4.42% | 3,427,825,906 | |
| 3,950,490 | Institution | 3.80% | 2,946,156,927 | |
| 3,943,648 | Institution | 3.80% | 2,941,054,369 | |
| 3,529,856 | Institution | 3.40% | 2,632,460,709 | |
| 2,620,146 | Institution | 2.52% | 1,954,026,282 | |
| 1,832,434 | Institution | 1.76% | 1,366,574,304 | |
| 1,770,005 | Institution | 1.70% | 1,320,016,629 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,645,779 | Institution | 6.40% | 4,956,222,605 | |
| 3,529,856 | Institution | 3.40% | 2,632,460,709 | |
| 1,770,005 | Institution | 1.70% | 1,320,016,629 | |
| 1,082,054 | Institution | 1.04% | 806,963,412 | |
| 737,686 | Institution | 0.71% | 550,144,088 | |
| 692,771 | Institution | 0.67% | 516,647,829 | |
| 625,173 | Institution | 0.60% | 466,235,268 | |
| 602,903 | Institution | 0.58% | 449,626,970 | |
| 592,161 | Institution | 0.57% | 441,615,909 | |
| 561,571 | Institution | 0.54% | 418,802,805 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,091,939 | Institution | 2.98% | 2,292,518,172 | |
| 2,567,653 | Institution | 2.47% | 1,903,786,317 | |
| 2,190,537 | Institution | 2.11% | 1,635,476,830 | |
| 1,233,645 | Institution | 1.19% | 920,015,432 | |
| 1,207,883 | Institution | 1.16% | 905,235,836 | |
| 1,174,548 | Institution | 1.13% | 876,929,282 | |
| 902,999 | Institution | 0.87% | 669,528,609 | |
| 733,902 | Institution | 0.71% | 547,322,095 | |
| 729,901 | Institution | 0.70% | 544,951,386 | |
| 685,035 | Institution | 0.66% | 511,453,981 |
FAQ
Who Owns Regeneron Pharmaceuticals (REGN)?
According to the latest TipRanks data, approximately 19.48% of the company's stock is held by institutional investors, 1.97% is held by insiders, and 25.80% is held by retail investors.
What percentage of Regeneron Pharmaceuticals (REGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.48% of Regeneron Pharmaceuticals (REGN) stock is held by institutional investors.
What percentage of Regeneron Pharmaceuticals (REGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.80% of Regeneron Pharmaceuticals (REGN) stock is held by retail investors.
Who owns the most shares of Regeneron Pharmaceuticals (REGN)?
Vanguard owns the most shares of Regeneron Pharmaceuticals (REGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.